Cardiology
RSSArticles
-
Bright-light Therapy for Daytime Sleepiness in Parkinson’s Disease Patients
Light therapy has been shown to be beneficial in treating excessive daytime sleepiness in Parkinson’s disease patients and also may improve sleep quality.
-
Pregabalin Not Effective for Reducing Pain in Acute or Chronic Sciatica
An Australian study of 207 patients suffering from acute and chronic clinically diagnosed sciatica did not find that treatment with pregabalin for eight weeks reduced pain at eight or 52 weeks.
-
Studying Surrogate Responses Can Improve Communication in Chronic Critical Illness
Qualitative analysis of audio-recorded structured meetings for patients with chronic critical illness revealed six categories of responses that clinicians can use to guide communication.
-
Muscle Weakness and Acute Respiratory Distress Syndrome: What Happens After the ICU?
Although increased strength at hospital discharge is associated with improved five-year survival in acute respiratory distress syndrome survivors, weakness at discharge, whether resolving or persistent, is associated with worse subsequent survival.
-
2016 Surviving Sepsis Guidelines Update
All ICU clinicians need to review these guidelines, compare them with their current practices, and develop plans for implementation in the near future.
-
Is This Fascicular Ventricular Tachycardia?
The ECG in the figure in this story was obtained from a 55-year-old man who presented for emergency care with palpitations and fatigue. His blood pressure was 80/50 mmHg at the time the tracing was recorded. Is this a case of ventricular tachycardia?
-
Clinical Briefs
In this section: treating depression; the subdural risk of antithrombotics; and the health consequences of a poor diet.
-
Ocrelizumab Injection (Ocrevus)
Ocrelizumab is indicated for the treatment of patients suffering from relapsing multiple sclerosis or primary progressive multiple sclerosis.
-
A New Risk Score for Stroke in Atrial Fibrillation
A new, simpler score for stroke risk prediction in atrial fibrillation patients uses biomarkers to supplant many clinical variables and outperforms the CHA2DS2-VASc score in two large cohorts.
-
Treating Erectile Dysfunction After Myocardial Infarction May Be Safe
In a Swedish nationwide cohort study of men < 80 years of age hospitalized for myocardial infarction, treatment for erectile dysfunction with phosphodiesterase-5 inhibitors resulted in lower mortality and heart failure hospitalization.